Health Secretary Robert F. Kennedy Jr. has announced the withdrawal of $500 million in federal funding aimed at developing mRNA vaccines for respiratory diseases, including Covid-19 and flu.
RFK Jr. Withdraws $500 Million Funding for mRNA Vaccine Projects
RFK Jr. Withdraws $500 Million Funding for mRNA Vaccine Projects
US Health Department's decision to axe funding raises concerns over future pandemic preparedness.
In a controversial move, the U.S. Department of Health and Human Services (HHS), led by Health Secretary Robert F. Kennedy Jr., has decided to terminate $500 million (£376 million) in funding intended for the development of mRNA vaccines targeting respiratory diseases. This decision affects 22 critical vaccine projects spearheaded by renowned pharmaceutical companies, such as Pfizer and Moderna, which were aimed at combating viruses like avian flu and Covid-19.
Kennedy, known for his skepticism toward vaccines, cited concerns that "mRNA technology poses more risks than benefits for these respiratory viruses." Health professionals and experts have condemned his views, arguing they undermine the established safety and efficacy of vaccines. Peter Lurie, a former FDA official, asserted that this funding withdrawal marks a significant setback for the country, potentially hindering the fight against future pandemics and delaying vaccine responses.
In his statement, Kennedy claimed his team reviewed the scientific evidence and expert opinions before making this decision. He emphasized that the current data indicate these vaccines inadequately protect against upper respiratory infections, thus planning to redirect funding towards "safer, broader vaccine platforms" that would adapt to viral mutations more effectively. Health experts have countered this assertion, noting that viral mutations occur independently of the presence of vaccines, as evidenced by the annual evolution of influenza.
Dr. Paul Offit, the director of the Vaccine Education Center at Children's Hospital of Philadelphia, defended mRNA vaccines as "remarkably safe" and vital for preventing severe infections, particularly during the Covid-19 pandemic. He warned that canceling this funding could leave the nation more vulnerable to future health crises, echoing concerns about mRNA vaccines’ rapid development cycles that were pivotal during the pandemic.
In addition to this funding withdrawal, Kennedy has been revamping the Department of Health's approach to vaccine development, notably dismissing an entire committee responsible for immunization recommendations and replacing it with figures who share his critical stance on vaccines. Critics are now left questioning the ramifications of Kennedy's policies on public health and the future of vaccine development in the United States.
